ClinicalTrials.govpublic full text
Cardiovascular and Torsades de Pointes Monitoring for Pazopanib
carcinoma, renal cell, adverse events, pazopanib, torsades des pointes, renal cell carcinoma, anti-vegf agents, observational data, cardiac ischemia, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 915679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.